NORDIC BIOSCIENCE HOLDING A/S: Financial statements 2017
CVR: 30511271
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
NORDIC BIOSCIENCE HOLDING A/S (CVR 30511271) has filed annual accounts for 2017. In 2017, the company reported a net result of DKK 289,728,320 compared with DKK 3,215,131 the year before. Equity in the 2017 report amounted to DKK 597,473,080. The solvency ratio was 66.6%. The company had 2 employees in the financial year.
- Profit/Loss
- DKK 289,728,320
- Equity
- DKK 597,473,080
- Total Assets
- DKK 897,490,950
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | - | 289.7 mio. | 597.5 mio. | 2 |
| 2016 | - | - | 3.2 mio. | 316.7 mio. | 133 |
| 2015 | - | 0 | 33.1 mio. | 310.5 mio. | 113 |
| 2014 | 111.8 mio. | 38.4 mio. | 40.4 mio. | 278.8 mio. | 104 |
| 2013 | - | -7.5 mio. | 98.5 mio. | 239.4 mio. | 99 |
Official annual report
Keep an eye on NORDIC BIOSCIENCE HOLDING A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
NORDIC BIOSCIENCE HOLDING A/S has published its annual report for 2016. The net result was DKK 3,215,131.
About NORDIC BIOSCIENCE HOLDING A/S
NORDIC BIOSCIENCE HOLDING A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 2007. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Morten Asser Karsdal. The board consists of Claus Henrik Christiansen (chair), Steffen Kragh, Henrik Bernt Sanders and Kugan Sathiyanandarajah. The company is owned by Nordic Life Science Consulting ApS, Romarine ApS and KKR Precision Aggregator L.P.. The company has 1 employee (2025). In 2025, the company reported revenue of DKK 426,285,000 and a net result of DKK 54,532,000 compared with DKK 170,813,000 the year before. Equity in the 2025 report amounted to DKK 71,184,000.